Fundz

Sigrid Therapeutics Raises Further Sek10.6 Million In Oversubscribed Rights Issue For Accelerated Sipore® Commercialization

PRIVATEJan 16, 2023

Amount Raised

SEK10.6 Million

Round Type

Seed

StockholmBiotechnology

Investors

Sigrid

Description

Sigrid Therapeutics, a Swedish consumer health and wellbeing company today announced that it has raised an additional SEK10.6 million to accelerate commercialization of its SiPore® health and food supplement portfolio. Both current and new investors participated including recently appointed Chairman, Mattias Ankarberg. In addition to the funds, Sigrid views Ankarberg's vast experience from the consumer industry, most recently at retail giant H&M, as ideal to help diversify its SiPore® technology into the food supplement, veterinary and oral health markets.

Quick answer

Sigrid Therapeutics raised SEK10.6 Million in a Seed round, dated January 16, 2023. Investors: Sigrid. Sigrid Therapeutics is based in Stockholm, Stockholm County, Sweden.

How much did Sigrid Therapeutics raise?
Sigrid Therapeutics raised SEK10.6 Million in a Seed round on January 16, 2023.
Who invested in Sigrid Therapeutics?
Sigrid is named as investors in this round.
What does Sigrid Therapeutics do?
Lifestyle diseases, caused by poor diet and physical inactivity among others, are rising worldwide.
Where is Sigrid Therapeutics based and how big is it?
Sigrid Therapeutics is based in Stockholm, Stockholm County, Sweden. Fundz records about 17 employees.
Who are the decision-makers at Sigrid Therapeutics?
Fundz holds 1 contact at Sigrid Therapeutics, including the Chief Commercial Officer (CCO). Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Sigrid Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Wilson Wolf Manufacturing raised an undisclosed amount on March 1, 2023.
  • A2 Biotherapeutics, Inc. raised $1.3M (Series B) on March 1, 2023.
  • SigTuple raised $4.5M (Seed) on March 1, 2023.
  • Chroma Medicine raised $135M (Series B) on March 1, 2023.
  • CARGO Therapeutics raised $200M (Series A) on March 1, 2023.
  • Cellular Logistics raised $50K (Seed) on March 1, 2023.

Who to call at Sigrid Therapeutics, and when

A new round usually means Sigrid Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sigrid Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sigrid Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sigrid Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sigrid Therapeutics

Location

Stockholm, Stockholm County, Sweden

About

Lifestyle diseases, caused by poor diet and physical inactivity among others, are rising worldwide. Each year 70% of all deaths globally – 40 million – are attributed to lifestyle diseases such as obesity, type 2 diabetes and heart disease. Sigrid is a clinical-stage biotech company driven by the vision to improve human health through material-based innovations. We are pioneering a new class of engineered materials to prevent and treat lifestyle disease more safely and effectively.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sigrid Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsKasper W., Chief Commercial Officer (CCO) hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Sigrid Therapeutics's next move

See what Strategic adds

Sigrid Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.